Polonsky WH, Fisher L, Guzman S, Villa-Caballero L, Edelman SV
GLP-1 medications work by mimicking a naturally occurring hormone produced in the intestines after eating
According to the Wegovy Summary of Product Characteristics (SmPC), the mechanism of action involves binding to GLP-1 receptors, slowing gastric emptying, reducing hunger signals, and promoting feelings of fullness
Related resources: Kisspeptin Profile Weight Loss Peptide Dosage Comparison Chart (2026) The three GLP-1 track peptides produce dramatically different weight loss outcomes
The increasing incidence of lifestyle-related diseases in the Asia Pacific is increasing the demand for GLP-1 drugs
Future Combinations Further clinical development has focused on the potential combination between DPP-4 inhibition and SGLT2 inhibition